
Ileana Popa
Examiner (ID: 7520, Phone: (571)272-5546 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633 |
| Total Applications | 1084 |
| Issued Applications | 181 |
| Pending Applications | 126 |
| Abandoned Applications | 804 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13552337
[patent_doc_number] => 20180327716
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2018-11-15
[patent_title] => MODIFIED CELLS FOR PRODUCTION OF BLOOD CELLS
[patent_app_type] => utility
[patent_app_number] => 15/333577
[patent_app_country] => US
[patent_app_date] => 2016-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15333577
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/333577 | MODIFIED CELLS FOR PRODUCTION OF BLOOD CELLS | Oct 24, 2016 | Abandoned |
Array
(
[id] => 13552337
[patent_doc_number] => 20180327716
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2018-11-15
[patent_title] => MODIFIED CELLS FOR PRODUCTION OF BLOOD CELLS
[patent_app_type] => utility
[patent_app_number] => 15/333577
[patent_app_country] => US
[patent_app_date] => 2016-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15333577
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/333577 | MODIFIED CELLS FOR PRODUCTION OF BLOOD CELLS | Oct 24, 2016 | Abandoned |
Array
(
[id] => 11954743
[patent_doc_number] => 20170258894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'NOVEL MUCOSAL VACCINATION APPROACH FOR HERPES SIMPLEX VIRUS TYPE-2'
[patent_app_type] => utility
[patent_app_number] => 15/299876
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 26771
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15299876
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/299876 | NOVEL MUCOSAL VACCINATION APPROACH FOR HERPES SIMPLEX VIRUS TYPE-2 | Oct 20, 2016 | Abandoned |
Array
(
[id] => 13533787
[patent_doc_number] => 20180318436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => METHODS AND MEANS FOR INDUCING AN IMMUNE RESPONSE
[patent_app_type] => utility
[patent_app_number] => 15/763601
[patent_app_country] => US
[patent_app_date] => 2016-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15763601
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/763601 | METHODS AND MEANS FOR INDUCING AN IMMUNE RESPONSE | Oct 19, 2016 | Abandoned |
Array
(
[id] => 14016539
[patent_doc_number] => 20190070263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => MODULATING GAMMA-C-CYTOKINE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 15/767133
[patent_app_country] => US
[patent_app_date] => 2016-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14089
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767133
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/767133 | Modulating gamma-c-cytokine activity | Oct 5, 2016 | Issued |
Array
(
[id] => 11513024
[patent_doc_number] => 20170080097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'DENDRIMERIC PLATFORM FOR CONTROLLED RELEASE OF DRUGS'
[patent_app_type] => utility
[patent_app_number] => 15/285650
[patent_app_country] => US
[patent_app_date] => 2016-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 9095
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15285650
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/285650 | DENDRIMERIC PLATFORM FOR CONTROLLED RELEASE OF DRUGS | Oct 4, 2016 | Abandoned |
Array
(
[id] => 13413213
[patent_doc_number] => 20180258149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => CAR T CELL THERAPIES WITH ENHANCED EFFICACY
[patent_app_type] => utility
[patent_app_number] => 15/760519
[patent_app_country] => US
[patent_app_date] => 2016-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 104086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15760519
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/760519 | CAR T CELL THERAPIES WITH ENHANCED EFFICACY | Sep 15, 2016 | Abandoned |
Array
(
[id] => 13672633
[patent_doc_number] => 20160375050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => METHODS AND COMPOSITIONS INVOLVING CHITOSAN NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 15/264551
[patent_app_country] => US
[patent_app_date] => 2016-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15264551
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/264551 | METHODS AND COMPOSITIONS INVOLVING CHITOSAN NANOPARTICLES | Sep 12, 2016 | Abandoned |
Array
(
[id] => 11697910
[patent_doc_number] => 09687807
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-27
[patent_title] => 'Natural water-insoluble encapsulation compositions and processes for preparing same'
[patent_app_type] => utility
[patent_app_number] => 15/258323
[patent_app_country] => US
[patent_app_date] => 2016-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12502
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15258323
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/258323 | Natural water-insoluble encapsulation compositions and processes for preparing same | Sep 6, 2016 | Issued |
Array
(
[id] => 14743977
[patent_doc_number] => 20190255162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => METHOD FOR PROVIDING TUMOUR-SPECIFIC T CELLS
[patent_app_type] => utility
[patent_app_number] => 15/751883
[patent_app_country] => US
[patent_app_date] => 2016-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15751883
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/751883 | METHOD FOR PROVIDING TUMOUR-SPECIFIC T CELLS | Aug 9, 2016 | Abandoned |
Array
(
[id] => 13790827
[patent_doc_number] => 20190008952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => ENHANCED IMMUNE RESPONSE IN AQUATIC SPECIES
[patent_app_type] => utility
[patent_app_number] => 15/748761
[patent_app_country] => US
[patent_app_date] => 2016-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11871
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748761
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748761 | ENHANCED IMMUNE RESPONSE IN AQUATIC SPECIES | Jul 26, 2016 | Abandoned |
Array
(
[id] => 13313839
[patent_doc_number] => 20180208456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => PROGRAMMABLE, SELF ASSEMBLING PATCHED NANOPARTICLES, AND ASSOCIATED DEVICES, SYSTEMS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 15/745897
[patent_app_country] => US
[patent_app_date] => 2016-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -96
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745897
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/745897 | PROGRAMMABLE, SELF ASSEMBLING PATCHED NANOPARTICLES, AND ASSOCIATED DEVICES, SYSTEMS AND METHODS | Jul 20, 2016 | Abandoned |
Array
(
[id] => 12137100
[patent_doc_number] => 20180015184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS'
[patent_app_type] => utility
[patent_app_number] => 15/208335
[patent_app_country] => US
[patent_app_date] => 2016-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 15403
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15208335
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/208335 | METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS | Jul 11, 2016 | Abandoned |
Array
(
[id] => 13778747
[patent_doc_number] => 20190002912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => TUMOR IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 15/737829
[patent_app_country] => US
[patent_app_date] => 2016-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15737829
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/737829 | TUMOR IMMUNOTHERAPY | Jun 16, 2016 | Abandoned |
Array
(
[id] => 12729535
[patent_doc_number] => 20180135012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => MEMBRANE-RECEIVER COMPLEX THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 15/573402
[patent_app_country] => US
[patent_app_date] => 2016-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 152267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15573402
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/573402 | MEMBRANE-RECEIVER COMPLEX THERAPEUTICS | May 12, 2016 | Abandoned |
Array
(
[id] => 11059605
[patent_doc_number] => 20160256567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA'
[patent_app_type] => utility
[patent_app_number] => 15/153211
[patent_app_country] => US
[patent_app_date] => 2016-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 35713
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15153211
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/153211 | COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA | May 11, 2016 | Abandoned |
Array
(
[id] => 12660427
[patent_doc_number] => 20180111975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 15/565811
[patent_app_country] => US
[patent_app_date] => 2016-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26487
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 373
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15565811
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/565811 | Nuclease-mediated regulation of gene expression | May 11, 2016 | Issued |
Array
(
[id] => 11059606
[patent_doc_number] => 20160256568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA'
[patent_app_type] => utility
[patent_app_number] => 15/153291
[patent_app_country] => US
[patent_app_date] => 2016-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 35747
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15153291
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/153291 | COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNA | May 11, 2016 | Abandoned |
Array
(
[id] => 11107859
[patent_doc_number] => 20160304829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'Automated Superparamagnetic Particle Handling System'
[patent_app_type] => utility
[patent_app_number] => 15/151587
[patent_app_country] => US
[patent_app_date] => 2016-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12813
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15151587
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/151587 | Automated Superparamagnetic Particle Handling System | May 10, 2016 | Abandoned |
Array
(
[id] => 11671573
[patent_doc_number] => 20170160294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'METHODS OF REVERSIBLY BINDING A BIOTIN COMPOUND TO A SUPPORT'
[patent_app_type] => utility
[patent_app_number] => 15/151610
[patent_app_country] => US
[patent_app_date] => 2016-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12815
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15151610
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/151610 | METHODS OF REVERSIBLY BINDING A BIOTIN COMPOUND TO A SUPPORT | May 10, 2016 | Abandoned |